Down-regulating UCA1 not only significantly inhibits cell proliferation in vitro and tumor growth in vivo, but also increases the sensitivity of cancer cells to different drugs and improves chemotherapeutic effect in various human cancer, including pancreatic cancer, which suggesting that UCA1 may become a potential tumor therapeutic target. This evidence concerns the gene UCA1 and neoplasm.